Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$147 Hold
8
﹤0.01% 3044
2026
Q1
$162 Hold
8
﹤0.01% 2786
2025
Q4
$153 Hold
8
﹤0.01% 2838
2025
Q3
$193 Hold
8
﹤0.01% 2672
2025
Q2
$156 Sell
8
-33
-80% -$488 ﹤0.01% 2647
2025
Q1
$527 Buy
41
+33
+413% +$531 ﹤0.01% 2674
2024
Q4
$138 Hold
8
﹤0.01% 2753
2024
Q3
$181 Sell
8
-459
-98% -$10.5K ﹤0.01% 2518
2024
Q2
$11.5K Hold
467
﹤0.01% 1034
2024
Q1
$15.4K Buy
+467
New +$15.9K ﹤0.01% 1592
2022
Q4
$278 Buy
+8
New +$280 ﹤0.01% 2243
2022
Q3
Sell
-8
Closed 565
2022
Q2
$0 Buy
+8
New +$269 ﹤0.01% 2112
2022
Q1
Sell
-8
Closed -$1K 573
2021
Q4
$1K Buy
+8
New +$359 ﹤0.01% 2029

Other funds holding ADNT

CoreCap Advisors's ADNT Position: Q2 2026 in Review

CoreCap Advisors held its Adient (ADNT) position steady in Q2 2026 at 8 shares worth $147. The position accounts for ﹤0.01% of the portfolio, ranked #3044.

CoreCap Advisors first reported a position in ADNT in Q4 2021 and has held it in 13 quarters since. The position peaked at $15.4K in Q1 2024. 314 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • CoreCap Advisors held 8 shares of Adient worth $147 as of Q2 2026.
  • CoreCap Advisors left its Adient share count unchanged in Q2 2026.
  • Adient made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #3044 holding.
  • CoreCap Advisors first reported a position in Adient in Q4 2021 and has held it in 13 quarters since.
  • CoreCap Advisors's Adient position peaked at $15.4K in Q1 2024.
  • 314 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.